Alerts will be sent to your verified email
Verify EmailAARTIDRUGS
Aarti Drugs
|
Morepen Laboratories
|
Solara Active Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
APIs Production Capacity
|
45937.0 MTPA | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.79 % | 0.87 % | n/a |
Financials
|
|||
5 yr Average ROE
|
19.9 % | 13.75 % | -8.31 % |
5yr average Equity Multiplier
|
2.08 | 1.84 | 1.98 |
5yr Average Asset Turnover Ratio
|
1.13 | 1.34 | 0.55 |
5yr Avg Net Profit Margin
|
8.4 % | 5.42 % | -5.56 % |
Price to Book
|
2.45 | 2.44 | 2.35 |
P/E
|
20.48 | 21.53 | 0.0 |
5yr Avg Cash Conversion Cycle
|
82.62 Days | 21.38 Days | 115.03 Days |
Inventory Days
|
66.37 Days | 53.55 Days | 106.31 Days |
Days Receivable
|
113.27 Days | 63.5 Days | 125.38 Days |
Days Payable
|
95.33 Days | 98.41 Days | 142.19 Days |
5yr Average Interest Coverage Ratio
|
9.51 | 39.33 | 0.55 |
5yr Avg ROCE
|
22.85 % | 15.84 % | 3.01 % |
5yr Avg Operating Profit Margin
|
14.52 % | 8.37 % | 10.34 % |
5 yr average Debt to Equity
|
0.49 | 0.04 | 0.69 |
5yr CAGR Net Profit
|
3.93 % | 23.42 % | n/a |
5yr Average Return on Assets
|
9.61 % | 7.36 % | -2.61 % |
Shareholdings
|
|||
Promoter Holding
|
55.38 % | 35.65 % | 37.23 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 40.74 % |
Change in Promoter Holding (3 Yrs)
|
-4.61 % | 1.11 % | -2.28 % |
Change in Mutual Fund Holding (3 Yrs)
|
5.58 % | 0.0 | -3.57 % |
Aarti Drugs
|
Morepen Laboratories
|
Solara Active Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|